These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11718211

  • 1. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB, Liu L, Yashar J, Glicksman AS.
    J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
    [Abstract] [Full Text] [Related]

  • 2. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 Oct; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 5. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 6. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 7. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J, Dai CH, Yu LC, Chen P, Li XQ, Shi SB, Wu JR.
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [Abstract] [Full Text] [Related]

  • 8. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
    Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S.
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
    [Abstract] [Full Text] [Related]

  • 9. Induction chemoradiotherapy followed by surgery for stage III non-small cell lung cancer.
    Yoneda S, Yamamoto M, Sakura M, Izumo T, Noguchi Y, Nishimura H, Sakai H, Gotoh I, Kobayashi K, Hayashi K.
    Jpn J Clin Oncol; 1993 Jun; 23(3):173-7. PubMed ID: 8394472
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 01; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 13. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W, Stamatis G, Stuschke M, Wilke H, Müller MR, Kolks S, Flasshove M, Schütte J, Stahl M, Schlenger L, Budach V, Greschuchna D, Stüben G, Teschler H, Sack H, Seeber S.
    Br J Cancer; 1999 Dec 01; 81(7):1206-12. PubMed ID: 10584883
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group.
    J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834
    [Abstract] [Full Text] [Related]

  • 15. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 17. Surgery after multimodality treatment for non-small-cell lung cancer.
    Stamatis G, Eberhard W, Pöttgen C.
    Lung Cancer; 2004 Aug 20; 45 Suppl 2():S107-12. PubMed ID: 15552790
    [Abstract] [Full Text] [Related]

  • 18. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul 20; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 19. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
    Eberhardt WE, Gauler TC, Lepechoux C, Stamatis G, Bildat S, Krbek T, Welter S, Grunenwald D, Fischer B, Rodrigo Hde L, Theegarten D, Le Chevalier T, Seeber S, Stuschke M, Poettgen C.
    Lung Cancer; 2013 Oct 20; 82(1):83-9. PubMed ID: 23957964
    [Abstract] [Full Text] [Related]

  • 20. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M.
    Cancer Chemother Pharmacol; 2006 Sep 20; 58(3):361-7. PubMed ID: 16331494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.